Stock Events

Stock Events

Elicera Therapeutics AB (ELIC.ST) Q2 2023 Earnings

29AugExpected

Q4 2022

Q1 2023

Q2 2023

-0.22

-0.18

-0.15

-0.11

Details

Expected EPS

N/A

Actual EPS

-0.2192

Surprise EPS

-0.22

Surprise Percent

+∞%

Description

Elicera Therapeutics AB (ELIC.ST) has reported earnings of -0.2192 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.